A quarter century ago, Barry Karger and his team published research in the journal Proceedings of the National Academy of Sciences that would help enable scientists to sequence the human genome. It marked the first time anyone had shown a reliable and high-resolution analytical technique for characterizing DNA molecules.
Penny Beuning’s research is based on relationships. Proteins, DNA, RNA in a dance of scientific compatibility.
Congratulations to several Chemistry & Chemical Biology students for their awards.
Frustrating, enigmatic and enlightening. That’s how Elise Miner describes her scientific research when striving to develop economically sustainable renewable energy sources.
Biopharmaceuticals, also known as biologics, are the fastest growing sector of the pharmaceutical industry and most people living today will probably take a biopharmaceutical or know someone who takes one.
The Clinical and Translational Science Institute (CTSI), which partners Tufts University Medical Center with Northeastern, Brandeis and a number of clinical affiliates, has been named a recipient of a Clinical and Translational Science Award from the National Institutes of Health.
Professor John Engen was interviewed for the February 2014 issue of Biopharm Inernational
Research collaboration between the Department of Chemistry and Chemical Biology and Empiriko has led to development of a device, which has been heralded as an artificial liver. The Biomimiks technology is designed to allow researchers to screen potential pharmaceuticals for toxic metabolites, bypassing the need for animal studies. Work at Northeastern involves department chair Graham […]
In December, Northeastern University’s biochemistry program became one of the first four in the nation to be accredited through the American Society for Biochemistry and Molecular Biology (ASBMB) – indicating that it meets or exceeds professional standards, giving students an advantage with prospective employers and graduate schools.
When Mark Naniong, S’14, began his co-op at the Boston-based Belfer Institute for Applied Cancer Sciences at Dana-Farber Cancer Institute last spring, becoming a scientist wasn’t on his radar. But his experiential learning opportunity at the world-renowned treatment and research facility gave him a rare opportunity to conduct cutting edge research that could have major implications for the general public—an impact that this fifth-year chemistry major hopes to cultivate in a future career in patent law. – See more at: http://www.northeastern.edu/news/2014/01/naniong/#sthash.Va4j7fzU.dpuf